Our current findings disclose that the role of antioxidants is necessary for the action of salidroside, but insufficient for the treatment of NAFLD, and also that the regulation on AMPK activity and lipid metabolism in hepatocytes is crucial. Here, PRKAA1 is linked to metabolic dysfunction-associated steatotic liver disease.